Engineering an AB5 protein carrier

Bruce R. Lichtenstein*, Birte Höcker

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

30 Downloads (Pure)

Abstract

The promise of biologic therapeutics is hindered by the challenge to deliver their activity to biochemically relevant sites within diseased cells. The favourable application of the natural protein carriers of the AB5 toxin family to this challenge has been restricted owing to still unresolved requirements for assembling non-native cargo into carrier complexes. Here, we clarify the properties of fusion peptides which allow co-assembly of a selected fluorescent protein cargo with the non-toxic B subunit of a heat-labile enterotoxin. We establish the influence of sequence length, sequence identity and secondary structure of these linking domains on the assembly and disassembly of the complexes. Through our engineering framework we identify several non-native, reduced length fusion sequences that robustly assemble with the native carriers, maintain their ability to deliver protein cargo to cells, and demonstrate substantially refined in vitro properties. Constructs based upon these sequences should prove directly applicable to a variety of protein delivery challenges, and the described design framework should find immediate application to other members of the AB5 protein carrier family.

Original languageEnglish
Article number12643
JournalScientific Reports
Volume8
Issue number1
DOIs
Publication statusPublished - 23 Aug 2018

Fingerprint

Dive into the research topics of 'Engineering an AB<sub>5</sub> protein carrier'. Together they form a unique fingerprint.

Cite this